Toxoplasma gondii is an obligatory intracellular parasite able to block the IFN-γ-induced up-regulation of major histocompatibility complex (MHC) class I and class II molecules. This facilitates parasite-mediated evasion of T-cell responses. Glycosylphosphatidylinositols (GPIs) are involved in the pathogenicity of protozoan parasites and we investigated if GPIs are responsible for inhibition of MHC expression on macrophages. In contrast to the blockade observed in cells infected with viable tachyzoites, T. gondii GPIs up-regulated MHC class I and class II molecules on the surface of both unstimulated and IFN-γ-stimulated primary murine macrophages. This effect was correlated to the ability of GPIs to increase the antigen presentation to CD8+ lymphocytes. T. gondii GPIs did not activate STAT1, one of the factors involved in the transcription of MHC class I and class II genes. However, the GPI-induced MHC class I up-regulation was abrogated by SN50, a specific NF-KB inhibitor. Up-regulation of surface MHC molecules by GPIs may lead to the elimination of non-infected cells of the host immune system, contributing to the immune escape strategy of T. gondii.
Medzhitov R. , Janeway Jr CAThe Toll receptor family and microbial recognition. Trends Microbiol2000 ; 8: 452-456.
5.
Banchereau J. , Briere F., Caux C. et al. Immunobiology of dendritic cells. Annu Rev Immunol2000 ; 18: 767-811.
6.
Mellman I., Steinman RMDendritic cells: specialized and regulated antigen processing machines . Cell2001; 106: 255-258.
7.
Guermonprez P., Valladeau J., Zitvogel L. et al. Antigen presentation and T cell stimulation by dendritic cells. Annu Rev Immunol2002; 20: 621-627.
8.
Mordue DG, Sibley LDIntracellular fate of vacuoles containing Toxoplasma gondii is determined at the time of formation and depends on the mechanism of entry. J Immunol1997; 159: 4452-4459.
9.
Ling YM, Shaw MH, Ayala C. et al. Vacuolar and plasma membrane stripping and autophagic elimination of Toxoplasma gondii in primed effector macrophages. J Exp Med2006; 203: 2063-2071.
10.
Andrade RM, Wessendarp M., Gubbels MJ et al. CD40 induces macrophage anti-Toxoplasma gondii activity by triggering autophagy-dependent fusion of pathogen containing vacuoles and lysosomes. J Clin Invest2006; 116: 2366-2377.
11.
McKee AS , Dzierszinski F., Boes M. et al. Functional inactivation of immature dendritic cells by the intracellular parasite Toxoplasma gondii . J Immunol2004; 173: 2632-2640.
12.
Lüder CGK , Lang T., Beuerle B. et al. Down-regulation of MHC class II molecules and inability to up-regulate class I molecules in murine macrophages after infection with Toxoplasma gondii . Clin Exp Immunol1998; 112: 308-316.
13.
Lüder CGK , Lang C., Giraldo-Velasquez M. et al. Toxoplasma gondii inhibits MHC class II expression in neural antigen-presenting cells by down-regulating the class II transactivator CIITA . J Neuroimmunol2003; 134: 12-24.
14.
Dobrovolskaia MA, Vogel SNToll receptors, CD14, and macrophage activation and deactivation by LPS. Microbes Infect2002 ; 4: 903-914.
15.
Wolk K., Kunz S., Crompton NE et al. Multiple mechanisms of reduced major histocompatibility complex class II expression in endotoxin tolerance. J Biol Chem2003; 278: 18030-18036.
16.
Wolk K., Docke WD, von Baehr V. et al. Impaired antigen presentation by human monocytes during endotoxin tolerance. Blood2000; 96: 218-223.
17.
Schofield L. , Hackett F.Signal transduction in host cells by a glycosylphosphatidylinositol toxin of malaria parasites. J Exp Med1993 ; 177: 145-153.
18.
Tachado SD, Schofield L.Glycosylphosphatidylinositol toxin of Trypanosoma brucei regulates IL-1α and TNF-α expression in macrophages by protein tyrosine kinase mediated signal transduction. Biochem Biophys Res Commun1994; 205: 984-991.
19.
Camargo MM, Almeida IC, Pereira ME et al. Glycosylphosphatidylinositol-anchored mucin-like glycoproteins isolated from Trypanosoma cruzi trypomastigotes initiate the synthesis of proinflammatory cytokines by macrophages. J Immunol1997; 158: 5890-5901.
20.
Debierre-Grockiego F., Azzouz N., Schmidt J. et al. Roles of glycosylphosphatidylinositols of Toxoplasma gondii. Induction of tumor necrosis factor-α production in macrophages. J Biol Chem2003; 278: 32987-32993.
21.
Debierre-Grockiego F., Hippe D., Schwarz RT et al. Toxoplasma gondii glycosylphosphatidylinositols are not involved in T. gondii-induced host cell survival. Apoptosis2007; 12: 781-790.
22.
Gavrilescu LC, Denkers EYInterleukin-12 p40- and Fas ligand-dependent apoptotic pathways involving STAT-1 phosphorylation are triggered during infection with a virulent strain of Toxoplasma gondii. Infect Immun2003; 71: 2577-2583.
23.
Grimwood BG , Hechemy K., Stevens RWToxoplasma gondii: purification of trophozoites propagated in cell culture. Exp Parasitol1979; 48: 282-286.
24.
Debierre-Grockiego F., Rabi K., Schmidt J. et al. Fatty acids isolated from Toxoplasma gondii reduce glycosylphosphatidylinositol-induced tumor necrosis factor α production through NF-KB inhibition. Infect Immun2007; 75: 2886-2893.
25.
Debierre-Grockiego F., Campos MA, Azzouz N. et al. Activation of TLR2 and TLR4 by glycosylphosphatidylinositols derived from Toxoplasma gondii . J Immunol2007; 179: 1129-1137.
26.
Striepen B. , Zinecker CF, Damm JB et al. Molecular structure of the `low molecular weight antigen' of Toxoplasma gondii: a glucose α1-4 N-acetylgalactosamine makes free glycosylphosphatidylinositols highly immunogenic . J Mol Biol1997; 266: 797-813.
27.
Rock KL, Rothstein L., Gamble S.Generation of class I MHCrestricted T-T-hybridomas. J Immunol1990; 145: 804-811.
28.
Lüder CGK , Walter W., Beuerle B., Maeurer MJ, Gross U.Toxoplasma gondii down-regulates MHC class II gene expression and antigen presentation by murine macrophages via interference with nuclear translocation of STAT1a. Eur J Immunol2001; 31: 1475-1484.
29.
Glimcher LH , Kara CJSequences and factors: a guide to MHC class-II transcription. Annu Rev Immunol1992; 10: 13-49.
30.
Van den Elsen PJ, Holling TM, Kuipers HF, van der Stoep N.Transcriptional regulation of antigen presentation . Curr Opin Immunol2004; 16: 67-75.
31.
Bach EA, Aguet M., Schreiber RDThe IFN gamma receptor: a paradigm for cytokine receptor signaling . Annu Rev Immunol1997; 15: 563-591.
32.
Muhlethaler-Mottet A., Di Berardino W., Otten LA et al. Activation of the MHC class II transactivator CIITA by interferon-gamma requires cooperative interaction between Stat1 and USF-1. Immunity1998; 8: 157-166.
Reith W., Siegrist CA, Durand B. et al. Function of major histocompatibility complex class II promoters requires cooperative binding between factors RFX and NF-Y. Proc Natl Acad Sci USA1994; 91: 554-558.
35.
Fontes JD, Kanazawa S., Jean D. et al. Interactions between the class II transactivator and CREB binding protein increase transcription of major histocompatibility complex class II genes. Mol Cell Biol1999; 19: 941-947.
36.
Piskurich JF , Linhoff MW, Wang Y. et al. Two distinct gamma interferon-inducible promoters of the major histocompatibility complex class II transactivator gene are differentially regulated by STAT1, interferon regulatory factor 1, and transforming growth factor beta. Mol Cell Biol1999; 19: 431-440.
37.
Giroux M., Schmidt M., Descoteaux A.IFN-gamma-induced MHC class II expression: transactivation of class II transactivator promoter IV by IFN regulatory factor-1 is regulated by protein kinase C-alpha . J Immunol2003; 171: 4187-4194.
38.
Fujita T., Reis LF, Watanabe N. et al. Induction of the transcription factor IRF-1 and interferon-β mRNAs by cytokines and activators of second-messenger pathways. Proc Natl Acad Sci USA1989; 86: 9936-9940.
39.
Van den Elsen PJ, Gobin SJP.The common regulatory pathway of MHC class I and class II transactivation. Microbes Infect1999; 1: 887-892.
40.
Deckert-Schlüter M., Schlüter D., Hof H. et al. Differential expression of ICAM-1, VCAM-1 and their ligands LFA-1, Mac-1, CD43, VLA-4, and MHC class II antigens in murine Toxoplasma encephalitis: a light microscopic and ultrastructural immunohistochemical study. J Neuropathol Exp Neurol1994; 53: 457-468.
41.
Schluter D. , Lohler J., Deckert M. et al. Toxoplasma encephalitis of immunocompetent and nude mice: immunohistochemical characterisation of Toxoplasma antigen, infiltrates and major histocompatibility complex gene products. J Neuroimmunol1991; 31: 185-198.
42.
Lyons RE, Anthony JP, Ferguson DJ et al. Immunological studies of chronic ocular toxoplasmosis: up-regulation of major histocompatibility complex class I and transforming growth factor beta and a protective role for interleukin-6. Infect Immun2001; 69: 2589-2595.
43.
Fischer HG, Bonifas U., Reichmann G.Phenotype and functions of brain dendritic cells emerging during chronic infection of mice with Toxoplasma gondii. J Immunol2000; 164: 4826-4834.
44.
Pepper M., Dzierszinski F., Wilson E. et al. Plasmacytoid dendritic cells are activated by Toxoplasma gondii to present antigen and produce cytokines. J Immunol2008; 180: 6229-6236.
45.
Male D., Pryce G.Synergy between interferons and monokines in MHC induction on brain endothelium . Immunol Lett1988; 17: 267-271.
46.
Wong D., Dorovini-Zis K.Upregulation of intercellular adhesion molecule-1 (ICAM-1) expression in primary cultures of human brain microvessel endothelial cells by cytokines and lipopolysaccharide . J Neuroimmunol1992 ; 39: 11-21.
47.
McCarron RM , Wang L., Racke MK et al. Cytokine-regulated adhesion between encephalitogenic T lymphocytes and cerebrovascular endothelial cells . J Neuroimmunol1993; 43: 23-30.
48.
Stins MF, Gilles F., Kim KSSelective expression of adhesion molecules on human brain microvascular endothelial cells. J Neuroimmunol1997; 76: 81-90.
49.
Aosai F., Rodriguez Pena MS, Mun HS et al. Toxoplasma gondii-derived heat shock protein 70 stimulates maturation of murine bone marrow-derived dendritic cells via Toll-like receptor 4. Cell Stress Chaperones2006; 11: 13-22.
50.
Schofield L. , Hewitt MC, Evans K. et al. Synthetic GPI as a candidate anti-toxic vaccine in a model of malaria. Nature2002 ; 418: 785-789.
51.
Stijlemans B., Nath Baral T., Guilliams M. et al. A glycosylphosphatidylinositol-based treatment alleviates trypanosomiasisassociated immunopathology. J Immunol2007; 179: 4003-4014.
